DUB

信号通路图

研究领域

抑制剂选择性比较

特异性亚型抑制剂

DUB产品

所有产品 DUB抑制剂(13) 新DUB产品

目录号	产品描述	文献引用	实验数据
S2243	Degrasyn (WP1130) Degrasyn (WP1130)是一种选择性deubiquitinase (DUB: USP5，UCH-L1，USP9x，USP14，和 UCH37)抑制剂，对Bcr/Abl也有抑制作用，也是一种JAK2传感器(不影响20S蛋白酶体)和转录激活剂(STAT)。	J Biol Chem, 2019, 294(12):4572-4582 Sci Adv, 2018, 4(9):eaar4666 Nucleic Acids Res, 2018, 46(2):823-839	Protein expression by western blot analysis of cell lysates from MCF-7, TAM^R-4 and 164^R-7 cells treated for 3 days with vehicle (0.1% DMSO), 1 uM or 1.5 uM WP1130.
S7130	PR-619 PR-619是一种非选择性的，deubiquitinylating enzymes (DUBs)可逆抑制剂，无细胞试验中EC50为1-20 μM。	Cell Metab, 2019, 29(5):1166-1181 Cell Rep, 2019, 27(6):1657-1665 Cell Rep, 2019, 26(11):3076-3086.e6	Ubiquitination inhibitor PYR-41 and deubiquitination inhibitor PR-619 pretreated macrophages with or without Teuvincenone F (25 μM) for 2 h, following stimulated with LPS (100 ng/ml) for 30 min, and then subjected to immunoprecipitation with anti-NEMO antibody followed by immunoblot analysis with specific antibodies. Similar results were obtained from three independent experiments.
S7132	P5091 (P005091) P5091 (P005091)是一种选择性的，有效的ubiquitin-specific protease 7 (USP7)（泛素特异性蛋白酶7）抑制剂，EC50为4.2 μM，与作用于USP47相似。	Nat Commun, 2019, 10(1):4184 Haematologica, 2019, 10.3324/haematol.2018.206227 J Exp Clin Cancer Res, 2019, 38(1):90	(e) MM.1S cells were treated with RRx-001 (1.25 μM), P5091 (3 μM) or RRx-001 plus P5091 for 12 h; protein extracts were analyzed for total DNMT activity using the EpiQuik DNMT activity kit (mean±s.d.; P<0.001; n=3). (f) MM.1S cells were treated with RRx-001 (1.25 μM), P5091 (3 μM) or RRx-001 plus P5091 for 12 h; protein lysates were then subjected to immunoblot analysis using antibodies specific against p21, HDM2, p53 or GAPDH.
S7134	IU1 IU1是一种细胞渗透性的，可逆的proteasome（蛋白酶体）选择性抑制剂，作用于USP14时，IC50为4.7 μ M，作用于IsoT时选择性高25倍。	Nucleic Acids Res, 2020, 48(2):736-747 J Exp Clin Cancer Res, 2019, 38(1):220 PLoS One, 2019, 14(11):e0225145	IU1 treatment increased levels of peIF2a in both WT and S63del L. Sciatic nerves were treated ex vivo with 200 lM IU1 for 16 hr and the levels of p-eIF2a and eIF2a were analyzed by western blot. A Student’s t-test was performed between treated and untreated conditions of the same genotype
S7135	LDN-57444 LDN-57444是一种可逆的竞争性的蛋白酶体抑制剂，抑制Uch-L1时，IC50为0.88 μM，比作用于亚型Uch-L3选择性高30倍。	J Cell Mol Med, 2017, 21(12):3641-3657	Representative results of Western blot showed the effects of LDN (10.0 μM) treatments on the expressions of LC3-II and LC3-I from Normoxia and OGD groups of cPKCc+/+ and cPKCc/ cortical neurons (n = 6 per group).
S6640^New	GNE-6640 GNE6640 selectively inhibits recombinant ubiquitin epecific peptidase 7(USP7), with IC50 values of 0.75 μM, 0.43 μM, 20.3 μM and 0.23 μM for full length USP7, USP7 catalytic domain, full length USP47 and Ub-MDM2, respectively.
S8904^New	USP25/28 inhibitor AZ1 AZ1是一种非竞争性的泛素特异性蛋白酶25（USP25）和泛素特异性蛋白酶28（USP28）的双重抑制剂，在Ub-RH110检测中对USP25和USP28的IC50分别0.62 μM和0.7 μM。
S6748^New	ML364 ML364是去泛素化酶USP2的小分子抑制剂，IC50为1.1 μM（以含内部淬灭荧光双泛素为底物）。
S7140	TCID TCID是一种DUB抑制剂，抑制ubiquitin C-terminal hydrolase L3（泛素C-末端水解酶L3），IC50为0.6 μM，作用于L1选择性高125倍。
S7133	P22077 P22077是一种ubiquitin-specific protease USP7（泛素特异性蛋白酶USP7）抑制剂，EC50为8.6 μM，也抑制USP47。	Biochem Biophys Res Commun, 2019, 512(3):479-485
S4920	b-AP15 b-AP15是一种deubiquitinases（去泛素化酶）抑制剂，识别19S蛋白酶体的，抑制Ub-AMC分解， IC50为2.1 μM。	Mol Cancer Ther, 2019, 18(6):1045-1056 PLoS One, 2019, 14(11):e0225145 Sci Adv, 2018, 4(9):eaar4666	A USP14 inhibitor directly inhibits OSCC cell proliferation and triggers apoptosis. (A-D) OSCC cells were treated with indicated doses of b-AP15 for 24 h. (A) Cell proliferation was monitored by CCK8 assay. b-AP15 dramatically decreased cancer cells viability in a dose-dependent manner (p < 0.01). All values represented means ± SD of three independent experiments and each was performed in triplicate. (B, C) Flow cytometry analysis indicated that b-AP15 triggered significant apoptosis of OSCC cells (p < 0.01). Data were obtained in more than three independent experiments. (D) Apoptosis-related proteins were examined by western blot analysis. Inhibition of USP14 with b-AP15 induced a massive increase of ubiquitinated proteins, which then triggered apoptosis of cancer cells, activating caspase 3 to induce cleavage of caspase 3 and PARP.
S8288	VLX1570 VLX1570是蛋白酶DUB的竞争性抑制剂，在体外IC50值约为10μM。
S7529	ML323 ML323 是强效的选择性的USP1-UAF1抑制剂，其IC50为76 nM。	J Exp Med, 2017, 214(12):3553-3563 Oncol Rep, 2017, 37(3):1419-1429

目录号	产品描述	文献引用	实验数据
S2243	Degrasyn (WP1130) Degrasyn (WP1130)是一种选择性deubiquitinase (DUB: USP5，UCH-L1，USP9x，USP14，和 UCH37)抑制剂，对Bcr/Abl也有抑制作用，也是一种JAK2传感器(不影响20S蛋白酶体)和转录激活剂(STAT)。	J Biol Chem,2019, 294(12):4572-4582 Sci Adv,2018, 4(9):eaar4666 Nucleic Acids Res,2018, 46(2):823-839	Protein expression by western blot analysis of cell lysates from MCF-7, TAM^R-4 and 164^R-7 cells treated for 3 days with vehicle (0.1% DMSO), 1 uM or 1.5 uM WP1130.
S7130	PR-619 PR-619是一种非选择性的，deubiquitinylating enzymes (DUBs)可逆抑制剂，无细胞试验中EC50为1-20 μM。	Cell Metab,2019, 29(5):1166-1181 Cell Rep,2019, 27(6):1657-1665 Cell Rep,2019, 26(11):3076-3086.e6	Ubiquitination inhibitor PYR-41 and deubiquitination inhibitor PR-619 pretreated macrophages with or without Teuvincenone F (25 μM) for 2 h, following stimulated with LPS (100 ng/ml) for 30 min, and then subjected to immunoprecipitation with anti-NEMO antibody followed by immunoblot analysis with specific antibodies. Similar results were obtained from three independent experiments.
S7132	P5091 (P005091) P5091 (P005091)是一种选择性的，有效的ubiquitin-specific protease 7 (USP7)（泛素特异性蛋白酶7）抑制剂，EC50为4.2 μM，与作用于USP47相似。	Nat Commun,2019, 10(1):4184 Haematologica,2019, 10.3324/haematol.2018.206227 J Exp Clin Cancer Res,2019, 38(1):90	(e) MM.1S cells were treated with RRx-001 (1.25 μM), P5091 (3 μM) or RRx-001 plus P5091 for 12 h; protein extracts were analyzed for total DNMT activity using the EpiQuik DNMT activity kit (mean±s.d.; P<0.001; n=3). (f) MM.1S cells were treated with RRx-001 (1.25 μM), P5091 (3 μM) or RRx-001 plus P5091 for 12 h; protein lysates were then subjected to immunoblot analysis using antibodies specific against p21, HDM2, p53 or GAPDH.
S7134	IU1 IU1是一种细胞渗透性的，可逆的proteasome（蛋白酶体）选择性抑制剂，作用于USP14时，IC50为4.7 μ M，作用于IsoT时选择性高25倍。	Nucleic Acids Res,2020, 48(2):736-747 J Exp Clin Cancer Res,2019, 38(1):220 PLoS One,2019, 14(11):e0225145	IU1 treatment increased levels of peIF2a in both WT and S63del L. Sciatic nerves were treated ex vivo with 200 lM IU1 for 16 hr and the levels of p-eIF2a and eIF2a were analyzed by western blot. A Student’s t-test was performed between treated and untreated conditions of the same genotype
S7135	LDN-57444 LDN-57444是一种可逆的竞争性的蛋白酶体抑制剂，抑制Uch-L1时，IC50为0.88 μM，比作用于亚型Uch-L3选择性高30倍。	J Cell Mol Med,2017, 21(12):3641-3657	Representative results of Western blot showed the effects of LDN (10.0 μM) treatments on the expressions of LC3-II and LC3-I from Normoxia and OGD groups of cPKCc+/+ and cPKCc/ cortical neurons (n = 6 per group).
S6640^New	GNE-6640 GNE6640 selectively inhibits recombinant ubiquitin epecific peptidase 7(USP7), with IC50 values of 0.75 μM, 0.43 μM, 20.3 μM and 0.23 μM for full length USP7, USP7 catalytic domain, full length USP47 and Ub-MDM2, respectively.
S8904^New	USP25/28 inhibitor AZ1 AZ1是一种非竞争性的泛素特异性蛋白酶25（USP25）和泛素特异性蛋白酶28（USP28）的双重抑制剂，在Ub-RH110检测中对USP25和USP28的IC50分别0.62 μM和0.7 μM。
S6748^New	ML364 ML364是去泛素化酶USP2的小分子抑制剂，IC50为1.1 μM（以含内部淬灭荧光双泛素为底物）。
S7140	TCID TCID是一种DUB抑制剂，抑制ubiquitin C-terminal hydrolase L3（泛素C-末端水解酶L3），IC50为0.6 μM，作用于L1选择性高125倍。
S7133	P22077 P22077是一种ubiquitin-specific protease USP7（泛素特异性蛋白酶USP7）抑制剂，EC50为8.6 μM，也抑制USP47。	Biochem Biophys Res Commun,2019, 512(3):479-485
S4920	b-AP15 b-AP15是一种deubiquitinases（去泛素化酶）抑制剂，识别19S蛋白酶体的，抑制Ub-AMC分解， IC50为2.1 μM。	Mol Cancer Ther,2019, 18(6):1045-1056 PLoS One,2019, 14(11):e0225145 Sci Adv,2018, 4(9):eaar4666	A USP14 inhibitor directly inhibits OSCC cell proliferation and triggers apoptosis. (A-D) OSCC cells were treated with indicated doses of b-AP15 for 24 h. (A) Cell proliferation was monitored by CCK8 assay. b-AP15 dramatically decreased cancer cells viability in a dose-dependent manner (p < 0.01). All values represented means ± SD of three independent experiments and each was performed in triplicate. (B, C) Flow cytometry analysis indicated that b-AP15 triggered significant apoptosis of OSCC cells (p < 0.01). Data were obtained in more than three independent experiments. (D) Apoptosis-related proteins were examined by western blot analysis. Inhibition of USP14 with b-AP15 induced a massive increase of ubiquitinated proteins, which then triggered apoptosis of cancer cells, activating caspase 3 to induce cleavage of caspase 3 and PARP.
S8288	VLX1570 VLX1570是蛋白酶DUB的竞争性抑制剂，在体外IC50值约为10μM。
S7529	ML323 ML323 是强效的选择性的USP1-UAF1抑制剂，其IC50为76 nM。	J Exp Med,2017, 214(12):3553-3563 Oncol Rep,2017, 37(3):1419-1429